Cargando…
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
Patients with chronic liver disease (CLD) and cirrhosis are at high risk for hepatocellular carcinoma (HCC). Current diagnostic tools for HCC detection include imaging techniques and serum biomarkers such as α-fetoprotein (AFP). Yet, these methods are limited in sensitivity and specificity to accura...
Autores principales: | Dengler, Mirko, Staufer, Katharina, Huber, Heidemarie, Stauber, Rudolf, Bantel, Heike, Weiss, Karl Heinz, Starlinger, Patrick, Pock, Hannelore, Klöters-Plachky, Petra, Gotthardt, Daniel N., Rauch, Peter, Lackner, Carolin, Stift, Judith, Brostjan, Christine, Gruenberger, Thomas, Kumada, Takashi, Toyoda, Hidenori, Tada, Toshifumi, Weiss, Thomas S., Trauner, Michael, Mikulits, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542263/ https://www.ncbi.nlm.nih.gov/pubmed/28526812 http://dx.doi.org/10.18632/oncotarget.17598 |
Ejemplares similares
-
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
por: Staufer, Katharina, et al.
Publicado: (2017) -
Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis
por: Staufer, Katharina, et al.
Publicado: (2023) -
Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration
por: Ortmayr, Gregor, et al.
Publicado: (2021) -
The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance
por: Alidzanovic, Lejla, et al.
Publicado: (2016) -
Intermediate Monocytes but Not TIE2-Expressing Monocytes Are a Sensitive Diagnostic Indicator for Colorectal Cancer
por: Schauer, Dominic, et al.
Publicado: (2012)